Welcome to the Shahi Lab

At the Shahi Lab, we investigate how obesity, diet, and gut microbiota influence immune responses and exacerbate autoimmune neuroinflammation in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Our research focuses on elucidating the molecular mechanisms linking gut microbiota-derived hydrogen sulfide (H₂S), H₂S-mediated post-translational protein modification (sulfhydration), GLP-1 receptor (GLP-1R) signaling, and CD4⁺ T cell immunometabolism to obesity-exacerbated severe MS. We also explore how maternal obesity, early-life nutrition, and gut microbiota dysbiosis shape long-term immune programming and susceptibility to MS in adulthood.

Our ultimate goal is to translate these mechanistic discoveries into innovative dietary, microbiome-targeted, and immunomodulatory therapeutic strategies to prevent or ameliorate obesity-exacerbated MS.

Research   Publications  

Shahi Shailesh

Shailesh Shahi, PhD

Title/Position
Assistant Professor of Pathology
Shahi Lab Members

From left to right: Abul Hasnat Nihad, Zarin Tasnim Haider,  Jeannie I. Thao, Shailesh K. Shahi, Cristina D. Dix, Gabe K. Hyvonen, Mallory J. Wurth, Alaa B. Ahmed